NuCana PLC (NCNA)
3.965
-0.02
(-0.38%)
USD |
NASDAQ |
May 02, 16:00
4.20
+0.24
(+5.93%)
After-Hours: 19:55
NuCana Cash from Financing (TTM): -0.0659M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.0659M |
September 30, 2023 | 0.0092M |
June 30, 2023 | -0.1072M |
March 31, 2023 | -0.1499M |
December 31, 2022 | -0.1994M |
September 30, 2022 | -0.323M |
June 30, 2022 | -0.3895M |
March 31, 2022 | -0.405M |
December 31, 2021 | -0.1348M |
September 30, 2021 | -0.672M |
June 30, 2021 | 77.16M |
March 31, 2021 | 79.58M |
December 31, 2020 | 79.32M |
Date | Value |
---|---|
September 30, 2020 | 79.93M |
June 30, 2020 | 2.178M |
March 31, 2020 | -0.1458M |
December 31, 2019 | -0.06M |
September 30, 2019 | 0.0034M |
June 30, 2019 | 0.2646M |
March 31, 2019 | 0.2684M |
December 31, 2018 | 0.2762M |
September 30, 2018 | 101.91M |
June 30, 2018 | 100.48M |
March 31, 2018 | 100.38M |
December 31, 2017 | 100.38M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.672M
Minimum
Sep 2021
79.93M
Maximum
Sep 2020
16.62M
Average
-0.0659M
Median
Dec 2023
Cash from Financing (TTM) Benchmarks
Adaptimmune Therapeutics PLC | 0.88M |
Biodexa Pharmaceuticals Plc | 12.76M |
Autolus Therapeutics PLC | -0.883M |
Mereo BioPharma Group PLC | 7.973M |
Bicycle Therapeutics PLC | 250.03M |